We are live on ! Find out more
HPG

Harvest Portfolios Group Portfolio holdings

AUM $6.06B
1-Year Est. Return 16.63%
This Fund
S&P 500
This Quarter Est. Return
-2.42%
1 Year Est. Return
+16.63%
3 Year Est. Return
+50.33%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2.12B
AUM Growth
-$61.3M
Cap. Flow
+$8.97M
Cap. Flow %
0.42%
Top 10 Hldgs %
27.01%
Holding
230
New
15
Increased
79
Reduced
119
Closed
12

Top Buys

Rank Stock Value
1
A icon
Agilent Technologies
A
+$51.2M
2
AMAT icon
Applied Materials
AMAT
+$19.1M
3
COST icon
Costco
COST
+$18M
4
BMY icon
Bristol-Myers Squibb
BMY
+$8.51M
5
ISRG icon
Intuitive Surgical
ISRG
+$6.11M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$45.9M
2
QCOM icon
Qualcomm
QCOM
+$16.7M
3
DIS icon
Walt Disney
DIS
+$15.7M
4
LLY icon
Eli Lilly
LLY
+$8.62M
5
NVDA icon
NVIDIA
NVDA
+$5.96M

Sector Composition

Rank Sector Weight
1 Healthcare 50.85%
2 Technology 18.9%
3 Financials 7.4%
4 Consumer Discretionary 5.83%
5 Communication Services 4.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UNH icon
1
UnitedHealth
UNH
$370B
$71.9M 3.39%
142,587
-7,639
-5% -$3.76M
JNJ icon
2
Johnson & Johnson
JNJ
$625B
$67.6M 3.19%
434,191
+3,822
+0.9% +$631K
AMGN icon
3
Amgen
AMGN
$222B
$59M 2.79%
219,556
-5,980
-3% -$1.49M
ABBV icon
4
AbbVie
ABBV
$435B
$54.6M 2.58%
366,248
+6,266
+2% +$920K
AZN icon
5
AstraZeneca
AZN
$250B
$53.8M 2.54%
397,017
+41,112
+12% +$5.62M
BSX icon
6
Boston Scientific
BSX
$71.5B
$53.6M 2.53%
1,014,749
+20,969
+2% +$1.1M
REGN icon
7
Regeneron Pharmaceuticals
REGN
$80.8B
$53.2M 2.51%
64,602
-4,659
-7% -$3.66M
MRK icon
8
Merck
MRK
$318B
$52.9M 2.5%
514,151
+52,886
+11% +$5.7M
BMY icon
9
Bristol-Myers Squibb
BMY
$132B
$52.8M 2.49%
909,437
+138,917
+18% +$8.51M
NVS icon
10
Novartis
NVS
$297B
$52.7M 2.49%
517,617
+28,079
+6% +$2.85M
LLY icon
11
Eli Lilly
LLY
$1.06T
$51.5M 2.43%
95,956
-16,719
-15% -$8.62M
ISRG icon
12
Intuitive Surgical
ISRG
$134B
$51.2M 2.42%
175,264
+19,564
+13% +$6.11M
ZTS icon
13
Zoetis
ZTS
$30B
$51.1M 2.41%
293,881
-9,322
-3% -$1.69M
SYK icon
14
Stryker
SYK
$130B
$51M 2.41%
186,786
+8,077
+5% +$2.32M
DHR icon
15
Danaher
DHR
$144B
$50.8M 2.4%
231,106
-13,617
-6% -$3.04M
ELV icon
16
Elevance Health
ELV
$85.5B
$50M 2.36%
114,717
-4,361
-4% -$1.98M
TMO icon
17
Thermo Fisher Scientific
TMO
$220B
$49.5M 2.33%
97,699
+3,476
+4% +$1.85M
MDT icon
18
Medtronic
MDT
$112B
$49.3M 2.33%
628,656
+60,063
+11% +$5.03M
ABT icon
19
Abbott
ABT
$187B
$49M 2.31%
506,041
+34,041
+7% +$3.58M
A icon
20
Agilent Technologies
A
$41.2B
$47.7M 2.25%
+426,938
New +$51.2M
ACN icon
21
Accenture
ACN
$108B
$37.6M 1.78%
122,591
-2,957
-2% -$932K
GOOGL icon
22
Alphabet (Google) Class A
GOOGL
$4.33T
$36.9M 1.74%
282,079
-30,553
-10% -$3.95M
MSFT icon
23
Microsoft
MSFT
$3.71T
$36.7M 1.73%
116,359
+3,833
+3% +$1.27M
TXN icon
24
Texas Instruments
TXN
$261B
$34.3M 1.62%
215,889
+12,172
+6% +$2.08M
AAPL icon
25
Apple
AAPL
$4.57T
$29.5M 1.39%
172,262
-29,733
-15% -$5.45M
1
2 3 4 5

Similar funds

EMPI
Elo Mutual Pension Insurance Espoo, Finland $6.06B AUM 24.33% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
JWBC
John W. Bristol & Co New York $6.08B AUM 16.51% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 26.7% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
CIS
Capital International Sarl Los Angeles, California $6.11B AUM 32.29% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Harvest Portfolios Group's Q3 2023 Portfolio in Review

As of Q3 2023, Harvest Portfolios Group held 230 positions worth $2.12B, down 2.8% from $2.18B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Harvest Portfolios Group's Q3 2023 filing shows 15 new, 79 increased, 119 reduced and 12 closed positions. Its largest new stake was Agilent Technologies: 426,938 shares worth $47.7M. The largest sale was Pfizer, an estimated $45.9M.

By sector, the portfolio is most concentrated in Healthcare at 51% of assets, up from 49% a quarter earlier, followed by Technology and Financials.

  • Harvest Portfolios Group's largest Q3 2023 buy was Agilent Technologies: 426,938 shares worth $47.7M.
  • Harvest Portfolios Group added most to Bristol-Myers Squibb in Q3 2023, an estimated $8.51M increase.
  • Harvest Portfolios Group's biggest Q3 2023 reduction was Pfizer, cutting an estimated $45.9M.
  • Harvest Portfolios Group fully exited Qualcomm in Q3 2023, selling an estimated $16.7M.
  • Harvest Portfolios Group's ten largest holdings make up 27% of its $2.12B portfolio in Q3 2023.
  • Harvest Portfolios Group opened 15 new positions and closed 12 in Q3 2023.
  • Harvest Portfolios Group's portfolio value fell 2.8% quarter-over-quarter to $2.12B.

Based on Harvest Portfolios Group's 13F filing for Q3 2023, filed 2 Nov 2023.